Sign Up to like & get
recommendations!
0
Published in 2018 at "Drug research"
DOI: 10.1055/a-0596-7288
Abstract: OBJECTIVE To enhance brain bioavailability for intranasally administered Eugenol-encapsulated-chitosan-coated-PCL-Nanoparticles (CS-EUG-PCL-NPs). METHODS Chitosan-coated-PCL-Nanoparticles (CS-PCL-NPs) were developed through double emulsification-solvent evaporation technique and further characterized for particle size, zeta potential, size distribution, encapsulation efficiency as well as…
read more here.
Keywords:
eug pcl;
cerebral ischemia;
drug;
pcl nps ... See more keywords